How does the COVID-19 prevention drug Evusheld work and who should receive it? An infectious disease specialist explains
- Written by Patrick Jackson, Assistant Professor of Infectious Diseases, University of Virginia
While many immunocompromised and high-risk patients may benefit from AstraZeneca's Evusheld, drug distribution and access have been uneven.AP Photo/Ted S. WarrenThe U.S. Food and Drug Administration granted emergency use authorization to AstraZeneca’s COVID-19 antibody drug Evusheld on Dec. 8, 2021. Infectious disease physician Patrick...